HomeTagsGilead Sciences

Gilead Sciences

Biotechnology

Gilead Names Dietmar Berger as Chief Medical Officer

News Desk - December 13, 2024

Gilead Sciences, Inc. announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become...

Biotechnology

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

News Desk - February 13, 2024

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or...

Healthcare

Trodelvy Demonstrates Positive Efficacy Treating Both Platinum-Ineligible and Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer

Business Wire - February 20, 2023

Gilead Sciences, Inc. announced new and updated positive results from three cohorts of the Phase 2 TROPHY-U-01 study of Trodelvy for the treatment of...